QuidelOrtho Reagents
Contract Opportunity Analysis
The Centers for Disease Control and Prevention (CDC) is seeking to award a sole-source contract to QuidelOrtho Corporation for the procurement of various OEM reagents essential for the VITROS 3600 systems utilized by the Division of Viral Hepatitis Laboratory Branch. The required reagents include HBsAg, HBeAg, Anti-HCV, Anti-HBs, Anti-HBC IgM, Anti-HBC, Anti-HAV IgM, Anti-HAV, along with related controls, calibrators, and maintenance supplies, all of which are critical for diagnostic testing and laboratory operations. Interested parties may submit capability statements to demonstrate their ability to meet the requirements, although the contract is anticipated to be awarded as a firm-fixed-price purchase order valued below the Simplified Acquisition Threshold, with bids due by February 19, 2026, at 5:00 PM EST. For further inquiries, interested vendors can contact Gary Morgan at glm5@cdc.gov or by phone at 770-488-2639.